Skip to content

Young women and pregnant women can effectively use vaginal rings and oral PrEP for HIV prevention

Dr Lulu Nair presenting to IAS 2021.

More insulin resistance and worse metabolic profiles in children with HIV, South African study shows

Slide from Claire Davies' presentation to IAS 2021.

Chemsex on the rise in Thailand and other Asian countries

Dr Stephane Wen-Wei Ku speaking at the International AIDS Society conference.

People with HIV can produce an adequate immune response to SARS-CoV-2

Maria Polo (bottom left) presenting to IAS 2021.

Improved treatment for cryptococcal meningitis, a leading cause of death in people with HIV

Dr David Lawrence (bottom left) presenting to IAS 2021.

Potent new anti-HIV drug only needs to be injected once every six months

Peter Stanic/Pixabay

Novel dual antibody therapy partially controls virulent HIV infection in monkeys off treatment

Zachary Strongin presenting to IAS 2021.

Studies confirm that hormone levels in trans women are not greatly affected by PrEP, or vice versa

Vitoria Berg Cattani (centre) presenting to IAS 2021.

Modelling suggests injectable cabotegravir is far more effective than daily oral PrEP for women

Diagram from Dr Sinead Delany-Moretlwe's e-poster presentation.